Development and verification of prognostic nomogram for ampullary carcinoma based on the SEER database
- PMID: 37313462
- PMCID: PMC10259652
- DOI: 10.3389/fonc.2023.1197626
Development and verification of prognostic nomogram for ampullary carcinoma based on the SEER database
Abstract
Background: Ampullary carcinoma (AC) is a rare cancer of the digestive system that occurs in the ampulla at the junction of the bile duct and pancreatic duct. However, there is a lack of predictive models for overall survival (OS) and disease -specific survival (DSS) in AC. This study aimed to develop a prognostic nomogram for patients with AC using data from the Surveillance, Epidemiology, and End Results Program (SEER) database.
Methods: Data from 891 patients between 2004 and 2019 were downloaded and extracted from the SEER database. They were randomly divided into the development group (70%) and the verification group (30%), and then univariate and multivariate Cox proportional hazards regression, respectively, was used to explore the possible risk factors of AC. The factors significantly related to OS and DSS were used to establish the nomogram, which was assessed via the concordance index (C-index), and calibration curve. An internal validation was conducted to test the accuracy and effectiveness of the nomogram. Kaplan-Meier calculation was used to predict the further OS and DSS status of these patients.
Results: On multivariate Cox proportional hazards regression, the independent prognostic risk factors associated with OS were age, surgery, chemotherapy, regional node positive (RNP),extension range and distant metastasis with a moderate C-index of 0.731 (95% confidence interval (CI): 0.719-0.744) and 0.766 (95% CI: 0.747-0.785) in the development and verification groups, respectively. While, marital status, surgery, chemotherapy, regional node positive (RNP),extension range and distant metastasis were significantly linked to AC patients' DSS, which have a better C-index of 0.756 (95% confidence interval (CI): 0.741-0.770) and 0.781 (95% CI: 0.757-0.805) in the development and verification groups. Both the survival calibration curves of 3- and 5-year OS and DSS brought out a high consistency.
Conclusion: Our study yielded a satisfactory nomogram showing the survival of AC patients, which may help clinicians to assess the situation of AC patients and implement further treatment.
Keywords: SEER; ampullary carcinoma; nomogram; overall survival; prognosis.
Copyright © 2023 Tang, Chen, Yang, Shang and Shi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Development and Verification of Prognostic Nomogram for Penile Cancer Based on the SEER Database.Biomed Res Int. 2022 Apr 4;2022:8752388. doi: 10.1155/2022/8752388. eCollection 2022. Biomed Res Int. 2022. PMID: 35419456 Free PMC article.
-
Prognostic Nomogram for Disease-Specific Survival in Patients with Non-metastatic Ampullary Carcinoma After Surgery.Ann Surg Oncol. 2019 Apr;26(4):1079-1085. doi: 10.1245/s10434-018-07115-8. Epub 2019 Jan 18. Ann Surg Oncol. 2019. PMID: 30659390 Free PMC article.
-
Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.Medicine (Baltimore). 2019 Nov;98(46):e17916. doi: 10.1097/MD.0000000000017916. Medicine (Baltimore). 2019. PMID: 31725640 Free PMC article.
-
Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma.Biomed Res Int. 2021 Nov 11;2021:6736008. doi: 10.1155/2021/6736008. eCollection 2021. Biomed Res Int. 2021. PMID: 34805402 Free PMC article.
-
Marital Status and Prognostic Nomogram for Bladder Cancer With Distant Metastasis: A SEER-Based Study.Front Oncol. 2020 Oct 27;10:586458. doi: 10.3389/fonc.2020.586458. eCollection 2020. Front Oncol. 2020. PMID: 33194738 Free PMC article.
Cited by
-
The Diagnosis and Treatment of Ampullary Carcinoma.Dtsch Arztebl Int. 2023 Oct 27;120(43):729-735. doi: 10.3238/arztebl.m2023.0195. Dtsch Arztebl Int. 2023. PMID: 37656482 Free PMC article. Review.
-
Comparison of clinical characteristics and prognostic factors in two site-specific categories of ampullary cancer.World J Gastroenterol. 2024 Oct 21;30(39):4281-4294. doi: 10.3748/wjg.v30.i39.4281. World J Gastroenterol. 2024. PMID: 39492830 Free PMC article.
-
Clinical and molecular characteristics of periampullary carcinoma based on pathological subtypes.J Gastrointest Oncol. 2025 Feb 28;16(1):249-263. doi: 10.21037/jgo-2025-14. Epub 2025 Feb 26. J Gastrointest Oncol. 2025. PMID: 40115922 Free PMC article.
-
Nomogram for overall survival in ampullary adenocarcinoma using the surveillance, epidemiology, and end results database and external validation.World J Clin Oncol. 2025 Feb 24;16(2):95910. doi: 10.5306/wjco.v16.i2.95910. World J Clin Oncol. 2025. PMID: 39995566 Free PMC article.
References
LinkOut - more resources
Full Text Sources